Polymorphic debrisoquine oxidation and acute neuroleptic-induced adverse effects

Eur J Clin Pharmacol. 1992;42(3):347-8. doi: 10.1007/BF00266363.

Authors

E Spina¹, M Ancione, A E Di Rosa, M Meduri, A P Caputi

Affiliation

¹ Institute of Pharmacology, University of Messina, Italy.

PMID: 1349529
DOI: 10.1007/BF00266363

No abstract available

MeSH terms

Adult
Antipsychotic Agents / adverse effects*
Antipsychotic Agents / metabolism
Debrisoquin / metabolism*
Female
Humans
Male
Middle Aged
Oxidation-Reduction
Phenotype
Polymorphism, Genetic
Retrospective Studies

Substances

Antipsychotic Agents
Debrisoquin